Motive Partners Closes Sale of Avaloq to NEC

Motive Partners

New York, December 22, 2020 – Motive Partners today announced that it has completed the sale of Avaloq, a Swiss-based technology provider of digital banking solutions, core banking software and wealth management technology, to NEC Corporation, a Japan-based IT group, for CHF 2.05 billion. The sale agreement was first announced in October 2020. Motive Capital Fund 1 acquired a stake in the company in January 2018.

As the world witnesses a democratization of wealth management, Avaloq is well placed to capitalize on geographic expansion with its new partner, and to lead in digital banking solutions for high-end wealth management services and private banks globally. The democratization of the sector and digital inclusion is going to be an essential topic in the future as we see wealth shift geographies, classes and generations. Market trends continue to produce net flow and fee pressure and with an increase in competition, the industry is seeing further pressure on wealth managers to deliver more value to clients while simultaneously reducing the cost-to-serve. As the industry consolidates across markets in order to scale, Motive Partners seeks to capitalize on these trends.

Rob Heyvaert, Managing Partner of Motive Partners said: “We saw great potential in Avaloq as a result of its history as a global leader in wealth management technology, the opportunity for up-sell and cross-sell opportunities within its existing blue-chip client base, and the opportunity to support this client base through a transition to a cloud-based SaaS platform. Additionally, Motive Partners supported the company as it expanded beyond its traditional home market of Switzerland into the U.K., Germany, and APAC. We enjoyed this exciting journey working together with Avaloq, and with its strong leadership in place, we are confident that Avaloq will enjoy continued success as part of NEC.”
Francisco Fernandez, Founder and Chairman of Avaloq commented: “I have enjoyed working with Motive Partners a great deal, who have proven to be a very supportive investor. Led by industry experts, they shared our collective ambitions while providing the strategic support to allow Avaloq to achieve it’s potential, today and for many years to come. NEC’s geographic footprint and ability to continue investing heavily in R&D will set us in great stead for the future. I am deeply grateful to my partners at Motive Partners, with whom I have grown close to, and I look forward to continuing our friendship.”

About Motive Partners
Motive Partners is a specialist private equity firm with offices in New York City and London, focusing on control-oriented growth equity and buyout investments in software and information services companies based in North America and Europe and serving five core sub-sectors across business and financial services: Banking & Payments, Capital Markets, Data & Analytics, Investment Management and Insurance. Motive Partners brings differentiated expertise, connectivity and capabilities to create long-term value in financial technology companies.
More information on Motive Partners can be found at www.motivepartners.com.

About Avaloq
Founded in 1985, Swiss-based Avaloq is a global leader in digital banking solutions, core banking software and wealth management technology. Avaloq provides powerful cloud computing solutions for banks and wealth managers through BPaaS and SaaS. Avaloq is the only independent banking software provider to develop and also operate its own software.
Its established core banking system is complemented by three innovative digital platforms – Engage, Wealth and Insight – providing end-to-end digital solutions at a level of simplicity that will pave the way for the democratization of wealth management. To further spur innovation, Avaloq connects its clients with selected Financial Technology companies through the Avaloq.one Ecosystem, the company’s open banking marketplace.
More than 150 banks and wealth managers with around CHF 4.5 trillion in assets managed worldwide trust Avaloq for its award-winning products and services. Avaloq has its headquarters in Zurich, Switzerland and employs more than 2,000 people around the world.
More information on Avaloq: An NEC Company can be found at www.avaloq.com.

Forward looking statements
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the expected timing and benefits of the transaction. Statements can generally be identified as forward- looking because they include words such as “believes,” “anticipates,” “expects,” “could,” “should,” or words of similar meaning. Forward-looking statements are subject to assumptions, risks and uncertainties that may cause actual results to differ materially from those contemplated by such forward-looking statements. The factors that may adversely impact the anticipated outcomes include, among others: the occurrence of any event, change or other circumstance that could give rise to the termination of the transaction agreement; conditions to the completion of the transaction may not be satisfied on the terms expected or on the anticipated timeline; and the benefits of the transaction may be different than currently anticipated. You should consider these factors carefully in evaluating forward-looking statements and are cautioned not to place undue reliance on such statements. Wilshire assumes no obligation to update any forward-looking statements, which speak only as of the date of this news release.

For more information please contact:
EMMA GLYN
Investor Relations, Motive Partners
emma.glyn@motivepartners.com

Categories: News

Tags:

Gryphon Investors Completes Majority Investment in Meazure Learning

Gryphon Investors

San Francisco, CA – December 22, 2020 —

Gryphon Investors (“Gryphon”), a leading middle-market private equity firm, announced today that it has become the majority investor in Meazure Learning (“Meazure” or the “Company”), a full-service exam delivery and online proctoring solution provider for academic, professional, and lifelong learners. Existing sponsor Eastside Partners will retain a significant ownership stake, as will the Company’s management team, including go-forward CEO Scott McFarland. Financial terms of the transaction were not disclosed.

Meazure Learning is the world’s largest remote exam proctoring company, also offering a full suite of assessment products and services, including proprietary exam development and delivery software as well as reporting and psychometric services, to the academic and professional testing markets. Based in Birmingham, AL, the Company employs nearly 300 people plus a network of over 1,300 trained proctors, and it serves more than 1,000 clients including major universities, certification and licensure associations, standardized testing services, and corporations.

Nick Orum, President and Co-Head of Gryphon’s Software Group, said, “Gryphon has invested previously in the education sector, and we are excited by the trends we’re seeing in the continued intersection of technology and learning. The increasing consumer preference for digitally driven flexibility has opened up a multi-billion-dollar market opportunity in the academic and professional remote testing spaces. We are thrilled to partner with the team at Meazure as we look to welcome new customers and reinforce the Company’s position as the most secure, convenient, and accessible experience for test-takers across the globe.”

Meazure’s management team will continue to be led by CEO McFarland and President Sandy Pitman. As part of the new partnership, Mr. Orum will join the Board of Directors, along with three additional Gryphon executives. Carl Theobald, Software Operating Partner, Jon Cheek, Principal in the Software Group, and Paul Margolis, Executive Advisor to Gryphon’s Software Group, will all join Eastside Partner Benjamin Cobb, who remains on the board.

Mr. Cheek commented, “Even before COVID-19, remote test-taking was undergoing a ‘Blockbuster to Netflix’ type transformation due to massive expansion in e-learning, a proliferation of professional training and certification programs, and a growing recognition of the test-taker convenience and cost savings offered by an online approach versus in-person testing. The pandemic has accelerated these growth trends beyond all expectations and given strong players like Meazure an enormous competitive advantage.”

Mr. Cobb added, “The pandemic has required many test owners to adopt remote proctoring solutions this year, often against the backdrop of 20+ years of in-person testing. We’ve helped testing organizations transition from uncertainty to excitement with remote testing due to some of its unique advantages – secure, safe, convenient, on-demand testing with global candidate reach. We’re excited to partner with Gryphon to better serve our customers and scale our solutions to support test owners whose needs aren’t being met.”

“We are delighted to partner with Gryphon as we plan for near-term, rapid expansion fueled by a changing industry and shifting expectations and requirements by test-takers,” said Mr. McFarland. “Their investment will allow us to solidify our position as a best-in-class remote testing and exam integrity platform and accelerate growth, both organically and through strategic acquisitions.”

Baird acted as financial advisor to Gryphon, and Raymond James was the financial advisor to Meazure. Kirkland & Ellis acted as legal advisor to Gryphon, and Bradley acted as legal advisor to Meazure. Terms of the deal were not disclosed.

About Meazure Learning
Meazure Learning (www.meazurelearning.com) is a full-service testing solutions company for academic, professional and lifelong learners. The result of a merger between ProctorU – the world’s largest provider of online, artificial-intelligence-augmented exam security and identity management solutions – and Yardstick Assessment Strategies – a leader in psychometrics and computer-based examination administration for professional testing organizations – Meazure Learning serves the higher education market via the ProctorU brand and the professional testing market via the Yardstick brand. As the first end-to-end testing provider to lead with an online delivery model, Meazure Learning is transforming the testing and assessment landscape.

About Gryphon Investors
Based in San Francisco, Gryphon Investors (www.gryphoninvestors.com) is a leading private equity firm focused on profitably growing and competitively enhancing middle-market companies in partnership with experienced management. The firm has managed over $5.0 billion of equity investments and capital since 1997. Gryphon targets making equity investments of $50 million to $300 million in portfolio companies with enterprise values ranging from approximately $100 million to $500 million. Gryphon prioritizes investment opportunities where it can form strong partnerships with owners and executives to build leading companies, utilizing Gryphon’s capital, specialized professional resources, and operational expertise.

Contacts

 

 

Categories: News

Tags:

EQT AB signs EUR 1 billion Revolving Credit Facility

eqt

On 21 December 2020, EQT AB (publ) signed a five-year EUR 1 billion revolving credit facility (the “RCF”), supported by a syndicate of global financial institutions.

The RCF will increase the financial flexibility of EQT and be used for corporate purposes, supporting the EQT AB Group’s growth initiatives and long-term strategy. The RCF will further incorporate a pricing mechanism linked to ESG-related objectives, lowering the interest rates if targets are met, and increasing them if targets are not achieved. It will thus be in line with EQT’s overall approach of integrating sustainability throughout its activities, both on EQT AB Group level and within funds advised by EQT. As announced earlier in 2020, EQT has launched ESG-linked bridge facilities both within the Private Capital and Infrastructure business lines, today totaling more than EUR 6 billion.

The RCF was arranged by Nordea and SEB (the “Bookrunners”). It attracted a strong level of interest during syndication and was significantly oversubscribed, displaying broad support for EQT’s strategy.

In addition to the Bookrunners, a total of 13 global financial institutions participated in the syndicate: Banco Santander, BNP Paribas, Crédit Agricole Corporate and Investment Bank, Credit Suisse, Deutsche Bank, DNB, Goldman Sachs, ING Wholesale Banking, J.P. Morgan, Mizuho Bank, Morgan Stanley, National Westminster Bank and Swedbank joined as Mandated Lead Arrangers.

Contact
Kim Henriksson, CFO, +46 8 506 55 300
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
Nina Nornholm, Head of Communications, +46 70 855 03 56
EQT Press Office, press@eqtpartners.com, +46 8 506 55 334

About EQT
EQT is a purpose-driven global investment organization with a 25-year track-record of consistent investment performance across multiple geographies, sectors, and strategies. EQT has raised more than EUR 75 billion since inception and currently has more than EUR 46 billion in assets under management across 16 active funds within two business segments – Private Capital and Real Assets.

With its roots in the Wallenberg family’s entrepreneurial mindset and philosophy of long-term ownership, EQT is guided by a set of strong values and a distinct corporate culture. EQT manages and advises funds and vehicles that invest across the world with the mission to future-proof companies, generate attractive returns and make a positive impact with everything EQT does.

The EQT AB Group comprises EQT AB (publ) and its direct and indirect subsidiaries, which include general partners and fund managers of EQT funds as well as entities advising EQT funds. EQT has offices in 16 countries across Europe, Asia-Pacific and North America with more than 700 employees.

More info: www.eqtgroup.com
Follow EQT on LinkedIn, Twitter, YouTube and Instagram

Categories: News

Tags:

Latour acquires Fristads AB, Kansas A/S, Kansas GmbH and Leijona Group Oy.

Latour logo

2020-12-11 08:45

Investment AB Latour has, through its fully owned subsidiary Hultafors Group AB, signed an agreement to acquire Fristads AB, Kansas A/S, Kansas GmbH and Leijona Group Oy from Fristads Kansas AB. The completion of the transaction is subject to regulatory approval and other customary closing conditions.

Fristads, Kansas and Leijona are leading brands in professional workwear for a variety of end-use segments and have strong footholds in their respective key markets Sweden, Denmark, Germany and Finland. Consolidated net sales is expected to amount to about 120 MEUR in 2020 and the companies together have more than 600 employees.

The acquisition is part of Hultafors Group’s strategy to grow and develop leading brands in the Personal Protection Equipment segment in Europe and North America.

“Hultafors Group’s acquisition of Fristads, Kansas and Leijona is aimed to drive customer value and we are very excited about the opportunities this combination creates. The brands will continue to operate separately, and in the long term we see opportunities to further strengthen our value proposition through synergies, primarily in warehouse management and supply chain”, says Camilla Monefeldt Kirstein, Executive Vice President at Business Unit Workwear within Hultafors Group.

“Fristads Kansas Group has in recent years made significant improvements with several important investments in product assortment, marketing and logistics/warehouse management. We are very proud of what we have achieved and we are now taking the next step to give all brands in our portfolio the best possible conditions to evolve. We are convinced that Hultafors Group will be an excellent new home for Fristads, Kansas and Leijona”, says Anders Davidsson, CEO of Fristads Kansas AB.

As an effect of the acquisition the net debt (excl. IFRS 16) of the Latour Group is expected to increase compared to the net debt level at the end of September 2020, to around SEK 6.9 billion, all else equal.

Göteborg, December 11, 2020

INVESTMENT AB LATOUR (PUBL)
Johan Hjertonsson, CEO

For further information, please contact:
Camilla Monefeldt Kirstein, EVP Business Unit Workwear, Hultafors Group AB, +46 734 333 634
Jens Eriksson, Vice President, M&A and Business Development Hultafors Group AB, +46 702 114 601

Hultafors Group is one of Europe’s largest companies to supply workwear, footwear, head protection, hand tools and ladders for professional users. The products are developed, manufactured and marketed as their own brands, which are available through leading distributors in about 40 markets, with emphasis on Europe and North America. Hultafors Group has more than 1,000 employees and rolling net sales of almost SEK 3.5 billion.

Investment AB Latour is a mixed investment company consisting primarily of a wholly-owned industrial operations and an investment portfolio of listed holdings in which Latour is the principal owner or one of the principal owners. The investment portfolio consists of nine substantial holdings with a market value of about SEK 66 billion. The wholly-owned industrial operations had an annual turnover of about SEK 15 billion in 2019.

Downloads

 

Categories: News

Tags:

IK Investment Partners supports independent financial advisor Valoria Capital

ik-investment-partners

IK Investment Partners (“IK”) is pleased to announce that the IK Small Cap II Fund has reached an agreement to invest in Valoria Capital (“Valoria” or “the Company”), a fast-growing acquisition platform of independent financial advisors. Financial terms of the transaction are not disclosed.

Founded in 2012 by serial financial services entrepreneur, Romain Lefèvre, Valoria serves several thousand customers offering a diversified range of saving products from a wide panel of leading asset managers and will manage over one billion Euros of assets under management by 2021.

Since its inception, the Company has exhibited tremendous growth, having successfully acquired and integrated 12smaller IFA boutiques since its founding and expanded its offering to incorporate complementary services including real estate, structure products, and corporate treasury optimisation.

IK will be supporting Romain Lefèvre in accelerating the group’s ambitious market consolidation and portfolio diversification strategy.

Romain Lefèvre, founder and CEO of Valoria, commented: “We’re delighted to welcome IK to support our fast-growing business operating in a market primed for consolidation. IK’s experience fostering operational excellence and ambitious M&A strategies make them the natural partner for Valoria in 2021 and beyond.”

Arnaud Bosc Partner at IK and advisor to the IK Small Cap II Fund, added: “Romain is a hands-on company founder with an exceptional achievement of success in the French IFA space. We’re thrilled to be supporting the next phase of Valoria’s growth by accelerating their buy-and-build strategy and their ongoing efforts to further diversify their offering and customer base.”

Pierre Gallix Partner at IK and advisor to the IK Small Cap II Fund, concluded: “We have been strongly impressed by Valoria’s track record over the past years and, we look forward working with Romain and his team onto the next growth chapter of the group.”

Parties involved with the transaction:

IK Investment Partners: Arnaud Bosc, Pierre Gallix, Morgane Bouhenic, Adrien Normand, Thierry Aoun, Pauline Lloret
M&A Advisor: Rothschild Transaction R (Philippe de Montreynaud)
Legal Advisor: Volt & Associés (Emmanuel Vergnaud, François-Joseph Brix, Alexandre Tron, François Jubin)
Financial / Legal / Tax / Social BDD: Grant Thornton (Emmanuel Riou, Valentin Noel, Alexis Martin, Stéphane Benezant, Caroline Luche-Rocchia, Cécile Didolot)
Financing: Idinvest Partners (Nicolas Nedelec, Olivier Sesboüé, Victoire Vanheuverswyn)
Management: Valoria (Romain Lefèvre)
M&A Advisor Seller: EY (Jean-Louis Duverney-Guichard, Alexandre Gebelin)
Legal Advisor Seller: Paul Hastings (Sebastien Crepy)
Legal Advisor Lenders: Willkie Far (Thomas Binet, Ralph Unger)
Financial VDD: EY (Marc-André Audisio, Emmanuel Villaire)

For further questions, please contact:

IK Investment Partners’ PR contact:

Maitland
James McFarlane
Phone: +44 (0)7584 142 665
jmcfarlane@maitland.co.uk

About Valoria Capital

Founded in 2012, Valoria Capital (“Valoria”) is a Paris-headquartered Independent Financial Advisor offering private clients, entrepreneurs, and their families, solutions to structure their wealth and manage their assets with complete objectivity. Valoria’s services are wholly tailored to the client and are entirely scalable. The company also provides complementary services encompassing real estate, credit, and tax advice. For more information, visit www.valoriacapital.fr

About IK Investment Partners

IK Investment Partners (“IK”) is a Pan-European private equity firm focused on investments in the Benelux, DACH, France, Nordics and the UK. Since 1989, IK has raised more than €13 billion of capital and invested in over 140 European companies. IK funds support companies with strong underlying potential, partnering with management teams and investors to create robust, well-positioned businesses with excellent long-term prospects. For more information, visit www.ikinvest.com

Categories: News

Tags:

Gilde-buy-out-partners acquires Tonerpartner group from Invision and founding-family

Gilde Buy Out

December 21, 2020 Frankfurt am Main / Hattingen – Funds advised by Gilde Buy Out Partners (“Gilde”) are pleased to announce that Gilde reached a binding agreement to acquire TonerPartner from its current shareholders Invision and its founding family. The terms of the agreement have not been disclosed. The transaction is subject to customary merger clearance approvals.
Founded in 1993 and based in Hattingen, TonerPartner is one of Europe’s leading online retailers specialised in the marketing of ink, toner, and printer cartridges for a wide range of printers in 16 European countries. The company offers one of the broadest portfolios of original branded products, high quality white label and own branded compatible alternatives, as well as environmentally friendly recycled products. TonerPartner has a loyal and growing end customer base with more than 4 million B2B and B2C customers served in recent years.
Peter Kroha, Partner at Invision, commented on the transaction: “We want to thank everyone at TonerPartner for their partnership and trust since our initial investment in 2016. We are proud of what has been achieved by this highly dedicated team and are delighted to have been able to support the company in becoming the leader in the European printing consumables segment. We are very pleased with the progress the company has made under our ownership and wish the team every success going forward. We are confident that TonerPartner will continue to prosper under its new owner Gilde.” Andreas Klab, Partner at Gilde, added: “We are impressed with TonerPartner’s track record of consistent growth, entrepreneurial spirit as well as its ability to fundamentally understand and cater to the demands of its customers. Under the leadership of its founding family and with support from Invision, the company has achieved a leading position in Europe. TonerPartner is well placed to build on this solid foundation and remain the most reliable player of scale within the printing consumables segment. We are excited to support TonerPartner in this next phase of development and growth.”
The founder of TonerPartner and Julian Zweers, Managing Director of TonerPartner, said: “We are thankful and humbled by the development of TonerPartner since its foundation almost 30 years ago. We have not only experienced exciting years with strong growth but have also pioneered the online segment in printing consumables. First and foremost, we would like to express our gratitude to all the staff at TonerPartner for their continued contribution and commitment over many years. The partnership with Invision was an outstanding one, which enabled TonerPartner to expand to regions outside of Germany. We are convinced that the sale of TonerPartner to Gilde will allow the company to further strengthen its position in the European market for printing consumables.” Read more at: https://gilde.com/news/2020/gilde-buy-out-partners-acquires-tonerpartner-group-from-invision-and-founding-family

Categories: News

columbus-enters-into-agreement-regarding-divestment-of-to-increase

Gilde Buy Out

Columbus enters into agreement regarding divestment of To-Increase December 21, 2020 Today, Columbus A/S entered into an agreement to divest its software subsidiary To-Increase to Gilde Buy Out Partners and the management of To-Increase for a price (Enterprise Value) of EUR 113m. The agreement has been entered into following a binding offer which Columbus received from Gilde Buy Out Partners today. The transaction is subject to Works Council consultation procedures being finalized in accordance with Dutch law. The transaction is expected to be completed during January 2021.
The agreement is part of the strategic review of Columbus’ portfolio and follows the decision made by Columbus’ Board of Directors to initiate a structured sales process to explore the possibility of divesting the software company To-Increase as part of Columbus’ new strategic direction to become a global consultancy. This decision was announced in Company Release no. 16/2020 of 28 October 2020.
Columbus’ decision of becoming a true global consultancy entails a more focused and simplified operation with increased customer centricity and a more digital advisory approach. The decision led Columbus to explore the opportunities to identify a buyer of To-Increase with a more aligned strategy and in a better position to realize the full potential of To-Increase.
Chairman of the Board in Columbus, Ib Kunøe, says: “I am very pleased to announce Gilde Buy Out Partners as the new owner of To-Increase. I am convinced Gilde Buy Out Partners will be a great owner of To-Increase which is a global SaaS leader of Azure based business applications. The divestment of To-Increase is a major step in Columbus’ strategic journey to become a true global consultancy. Columbus can now focus its business on becoming a digital trusted advisor for our larger customers”.
Maurits Boomsma, Partner at Gilde Buy Out Partners says: ”We look forward to partnering with the management team led by Luciano Cunha and to supporting their growth plans. To-Increase is an established leader in the fast-growing Microsoft Dynamics based business applications software market with innovative software solutions for their customers. With the right backing, we believe To-increase is well positioned for a phase of organic growth acceleration, continuing its track record of double-digit recurring revenue growth and further bolt-on M&A”.
Luciano Cunha, CEO in To-Increase, says: “I want to thank Columbus for an exciting journey during the past 14 years contributing to positioning To-Increase as a global SaaS leader, and I look forward to continuing our close partnership in the years to come. We firmly believe Gilde Buy Out Partners is the right partner to help us accelerate the growth of our business and realize the full potential of To-Increase. Gilde Buy Out Partners understands and believes in our business plans and can provide the support needed to realize our ambitions. This new partnership will enable us to scale through the Microsoft Dynamics 365 channel by using technology to help our customers reach their goals. Our growth plans include scaling up our Go-To-Market teams and executing on high quality M&A to make a bigger impact on our combined customers and our focus markets.” Columbus is committed to support and resell To-Increase Software as a global strategic A-Partner and To-Increase is continuing to enable Columbus as a successful strategic partner.

Categories: News

Tags:

Sylak AB is now successfully integrated into Observe Medical and in full operations

Reiten

Observe Medical ASA, December 21, 2020: Following the acquisition by Observe Medical of Sylak AB on October 30, the team and product portfolio are now successfully integrated into Observe Medical and in full operations, with focus on the Swedish market.

Observe Medical is currently launching Sippi® automated digital urine meter in selected markets in Europe, with the near-term focus of accelerating Sippi clinical use in Nordics. Therefore, the access to Sippi target customers is key, specifically important during the current pandemic, since the access to healthcare professionals is restricted, especially at ICUs and other departments at hospitals. The portfolio added through the acquisition of Sylak consists of a broad range of hospital products within urine measurement, anaesthesia/ICU and wound care. The product range is complimentary to Sippi, providing access and enabling sales calls with Sippi target customers. It has already generated several customer requests for Sippi testing and implementation during early 2021 at key hospitals. In addition, the integration has brought significant synergies by enhancing Observe Medical sales operational capabilities, for example in tender management, logistics and warehousing.

The Observe Medical sales team is further expanding with a new Nordic key account manager (KAM), joining in January 2021. The new KAM, like the colleagues in the sales team, has a background as a specialist nurse, a highly relevant competence and experience for driving Sippi clinical use as well as for the sales growth of the full Observe Medical portfolio. In the coming period the sales operations will further expand with direct sales team on the ground in the Nordics. With the strong international experience in the sales team, they are also key in transferring the Nordic Sippi references and learnings when enhancing our international distributor network.

“The pandemic is highlighting key clinical challenges, not the least at ICUs and other hospital departments. Our sales team has excellent and long-standing relations with the departments at major hospitals. It is highly motivating for me and my team to be fully on board Observe Medical, and to continue helping our customers, the caregivers, in their daily work with patients. Sippi has the same target customers as the rest of our portfolio and several of the products are directly synergistic and can be bundled with Sippi”. I expect this to further drive Sippi clinical use and portfolio sales growth” says Anders Nachtweij, Head of Sales, Observe Medical, formerly General Manager of Sylak.

“We are excited to move into 2021 with full speed and force, and further accelerate Sippi clinical use and portfolio sales growth in the Nordics – lead by Anders Nachtweij, our new Head of Sales, and his team. The integration of the Sylak team represents a boost of momentum and energy in a critical phase of the Sippi commercialization and for Observe Medical,” says Björn Larsson, CEO of Observe Medical.

For further information, please see company press release

Categories: News

Tags:

Nordic Capital and Astorg invest in pharmaceutical technology and advanced analytics company Cytel

Nordic Capital

December 21 2020
Nordic Capital and Astorg invest in pharmaceutical technology and advanced analytics company Cytel Image

 

  • Cytel is one of the leading global providers of clinical trial design technology, biometric services and advanced analytics, focusing on optimizing clinical trials and helping pharmaceutical companies to unlock the full potential of their clinical and real-world data
  • Nordic Capital and Astorg will actively support and accelerate Cytel’s next phase of growth and innovation, drawing on their extensive experience of investing in healthcare and technology

Nordic Capital and Astorg today announced an agreement to jointly acquire Cytel Inc. (“Cytel”), from New Mountain Capital. Cytel is one of the largest providers of statistical software and advanced analytics for clinical trial design and biometrics execution. Building on Cytel’s advanced software platform and leading biometrics services offerings, the new owners will invest in the continued development of the business and its software. Cytel’s mission is to continue providing life sciences companies with cutting-edge clinical trial optimization technologies and harness the full value of their clinical and real-world data. Cytel’s management team, led by CEO Josh Schultz, will continue to lead the organization, building on a strong track-record of organic growth and strategic acquisitions.

Cytel is recognized as an industry pioneer of adaptive clinical trials and other innovative quantitative methods, helping biotech and pharmaceutical companies to reduce risk, increase R&D productivity and support medical innovation, improving speed, productivity and efficiency of clinical trials. The Company was founded over 30 years ago by renowned statisticians Cyrus Mehta and Nitin Patel, thought-leaders in statistical science, who will continue to be active in the Company.

Headquartered in Waltham, Massachusetts, Cytel has more than 1,500 employees across North America, Europe and Asia. Cytel’s software and services are used by over 500 life sciences customers, including the world’s 30 top pharmaceutical companies, as well as regulatory bodies such as the FDA.

“We are delighted to welcome Nordic Capital and Astorg as our new owners and partners. They have an extensive track-record of commitment to medicine and data science, and we share several common experiences in developing and growing leading healthcare and technology businesses. It is this common foundation of vision and values which makes them ideal to support our continued growth and strategy. With Nordic Capital and Astorg, we have strong new partners at our side with expertise networks, cultural fit and a focus on innovation and quality that will benefit both our customers and employees. I also want to thank New Mountain Capital for their support over the last several years. They have helped us achieve our strategic objectives and we are now ready to take the next step on our journey,” said Joshua Schultz, CEO, Cytel.

“Cytel is a fantastic company. We’ve been impressed with its unique position, outstanding reputation and trust within complex clinical trials and statistical science, and we look forward to supporting Cytel’s expansion in partnership with the management team and founders,” said Judith Charpentier, Partner and Head of Healthcare, Astorg. “Together, we will fuel Cytel’s growth, with a shared vision of building a leading provider of advanced analytics and software for the life sciences industry,” said Daniel Berglund, Partner, Nordic Capital Advisors.

“We are proud of Cytel’s leading position and growth in enabling clinical trial optimization for the advancement of life-saving therapeutics. Over the past three years, New Mountain supported the transformation of Cytel into a cutting-edge pharma technology and analytics platform through strategic acquisitions and organic business building,” said Kyle Peterson, Managing Director, New Mountain Capital. “New Mountain partnered with Cytel in 2017 as a result of the firm’s sector deep dive in life sciences and technology-enabled business service companies that both raise quality and lower cost. We believe in the strong value proposition of the Company and are confident that Cytel’s management, in partnership with Nordic Capital and Astorg, will continue the Company’s successful path forward,” said Matt Holt, Managing Director, and President of Private Equity at New Mountain Capital.

The terms of the transaction were not disclosed. The transaction is subject to customary regulatory approvals.

Barclays and Rothschild & Co served as financial advisors to New Mountain Capital.

About Cytel

Cytel is the largest provider of statistical software and advanced analytics for clinical trial design and execution. For over thirty years, Cytel’s scientific rigor and operational excellence have enabled biotech and pharmaceutical companies to navigate uncertainty, prove value and make confident, evidence-based decisions. Its experts deliver industry-leading software, data-driven analytics, real-world evidence and strategic consulting. Headquartered in Waltham, Massachusetts, Cytel has more than 1,500 employees across North America, Europe and Asia. For more information about Cytel, please visit us at www.cytel.com.

About Nordic Capital

Nordic Capital is a leading private equity investor with a resolute commitment to creating stronger, sustainable businesses through operational improvement and transformative growth. Nordic Capital focuses on selected regions and sectors where it has deep experience and a long history. Focus sectors are Healthcare, Technology & Payments, Financial Services, and selectively, Industrial & Business Services. Key regions are Europe and globally for Healthcare and Technology & Payments investments. Since inception in 1989, Nordic Capital has invested more than EUR 15.5 billion in over 110 investments. The most recent fund is Nordic Capital Fund X with EUR 6.1 billion in committed capital, principally provided by international institutional investors such as pension funds. Nordic Capital Advisors have local offices in Sweden, Denmark, Finland, Norway, Germany, the UK and the US. For further information about Nordic Capital, please visit www.nordiccapital.com

Footnote: “Nordic Capital” refers to any, or all, Nordic Capital branded or associated investment vehicles and their associated management entities. Nordic Capital is advised by several non-discretionary sub-advisory entities, any or all of which is referred to as “Nordic Capital Advisors”.

About Astorg

Astorg is a leading independent private equity firm with over €9 billion of assets under management. We work with entrepreneurs and management teams to acquire market leading global companies headquartered in Europe or the US, providing them with the strategic guidance, governance and capital they need to achieve their growth goals. Astorg enjoys a distinct entrepreneurial culture, a long-term shareholder perspective, and a lean decision-making body. We have valuable industry expertise in healthcare, software, business-to-business professional services and technology- based industrial companies. Astorg has offices in London, Paris, New York, Frankfurt, Milan and Luxembourg. For more information about Astorg: www.astorg.com. Follow us on LinkedIn.

About New Mountain Capital

New Mountain Capital is a New York-based investment firm that emphasizes business building and growth, rather than debt, as it pursues long-term capital appreciation. The firm currently manages private equity, public equity, and credit funds with $28 billion in assets under management. New Mountain seeks out what it believes to be the highest quality growth leaders in carefully selected industry sectors and then works intensively with management to build the value of these companies. For more information on New Mountain Capital, please visit www.newmountaincapital.com 

 

Press contacts

Cytel
Rebecca Grimm
VP, Marketing
Tel: +1 781 755 8032
e-mail: rebecca.grimm@cytel.com

Nordic Capital
Katarina Janerud, Communications Manager
Nordic Capital Advisors
Tel: +46 8 440 50 50
e-mail: katarina.janerud@nordiccapital.com

Astorg
Stéphanie Tabouis
Publicis Consultants
Tel: +33 6 03 84 05 03
e-mail: stephanie.tabouis@publicisconsultants.com

New Mountain Capital
Dana Gorman / Claire Walsh
Abernathy MacGregor
Tel: +1 212 371 5999
e-mail: dtg@abmac.com / cw@abmac.com

Eurazeo has reached an agreement to sell its stake in C2S to Elsan

Eurazeo

Paris, December 21, 2020
Eurazeo Patrimoine, the Eurazeo arm specializing in real estate and companies that own and operate physical assets, has formed an agreement with Elsan to sell its stake in C2S, a multi-regional group of clinics specializing in general medicine, with 17 clinics in the Auvergne Rhône-Alpes and Bourgogne Franche-Comté regions of France.

For Eurazeo Patrimoine, the disposal would generate a cash-on-cash multiple of 3.2 x and an internal rate of return (IRR) of around 48%. Eurazeo’s proceeds from the disposal would be c. €400 million. This deal would crystallize a value of more than €2 per share on top of the Group’s Net Asset Value published as of 30 June 2020.

Since acquiring C2S in 2018, Eurazeo Patrimoine has played a hands-on role, supporting the group by providing it with the human resources and funding necessary for its development. As a result, the group has doubled its business in the space of only three years and extended its network into Eastern France, integrating seven new clinics and strengthening C2S’s geographical coverage so that it can treat patients as closely as possible to their homes.
During this phase of growth, the shared strategic vision of its management team and the support of Eurazeo Patrimoine have enabled C2S instill its values of proximity, quality, balanced medical and managerial governance and responsible development even more deeply within its business model.

Eurazeo Patrimoine’s support for C2S has yielded some major investment programs. In terms of real estate, the group has carried out extensions and refurbishments, created operating wings and introduced new out-patient and emergency services, with the aim of modernizing its clinics and helping to develop the business. In medical terms, the group has invested in robotic surgery including France’s first CMR robot, aiming to provide clinics and practitioners with tools at the leading edge of technology and to offer excellent care to patient close to their homes. It has also invested in digital technology, through digital patient pathways and a stronger partnership with Doctolib, in which Eurazeo is one of the main investors.

Renaud Haberkorn, Managing Partner at Eurazeo and head of Eurazeo Patrimoine, said:
“We are very proud of how far we have come over the last three years, working alongside the C2S management team. With the hard work done by Jean Rigondet and his teams, and with the support of Eurazeo, C2S has bolstered its structure, doubled its business, carried out strategic acquisitions and developed a medical research platform .This validates Eurazeo Patrimoine’s expertise at the crossroads between real estate and private equity.”
Jean Rigondet, Chairman of the C2S group, added:
”Our relationship with Eurazeo Patrimoine’s teams has been one of open communication and great mutual trust. This has been crucial in enabling us to transform our group in the last three years. We are delighted with the progress that C2S has achieved, which means that we can meet our patients’ needs ever more effectively and offer them high-quality care across a range of disciplines, by leveraging on a very high quality medical and paramedical team.”

About Eurazeo
• Eurazeo is a leading global investment company, with a diversified portfolio of €18.8 billion in assets under management, including €13.3 billion from third parties, invested in over 430 companies. With its considerable private equity, real estate and private debt expertise, Eurazeo accompanies companies of all sizes, supporting their development through the commitment of its nearly 300 professionals and offering in-depth sector expertise, a gateway to global markets, and a responsible and stable foothold for transformational growth. Its solid institutional and family shareholder base, robust financial structure free of structural debt, and flexible investment horizon enable Eurazeo to support its companies over the long term.
• Eurazeo has offices in Paris, New York, Sao Paulo, Seoul, Shanghai, London, Singapore, Luxembourg, Frankfurt, Berlin and Madrid.
• Eurazeo is listed on Euronext Paris.
ISIN: FR0000121121 – Bloomberg: RF FP – Reuters: EURA.PA

EURAZEO CONTACTS

PRESS CONTACT

PIERRE BERNARDINBERNARDIN

HEAD OF INVESTOR RELATIONS
email: pbernardin@eurazeo.com
Tel: +33 (0)1 44 15 16 76

VIRGINIE CHRISTNACHT
HEAD OF COMMUNICATIONS
mail: vchristnacht@eurazeo.com
Tel: +33 (0)1 44 15 76 44

MAITLAND/amo
DAVID STURKEN
mail: dsturken@maitland.co.uk
Tel: +44 (0) 7990 595 913

Categories: News

Tags: